Shuo Ni

1.1k total citations · 1 hit paper
25 papers, 817 citations indexed

About

Shuo Ni is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuo Ni has authored 25 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuo Ni's work include Bone Metabolism and Diseases (6 papers), Ferroptosis and cancer prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Shuo Ni is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Ferroptosis and cancer prognosis (4 papers) and MicroRNA in disease regulation (3 papers). Shuo Ni collaborates with scholars based in China, United States and Sweden. Shuo Ni's co-authors include Yanbin Kuang, Yin Yuan, Zeyuan Zhong, Xiaolin Li, Zhi Qian, Baoqing Yu, Yuan Yin, Dejian Li, Baoqing Yu and Aoxiang Zhuge and has published in prestigious journals such as Free Radical Biology and Medicine, Frontiers in Immunology and International Journal of Biological Macromolecules.

In The Last Decade

Shuo Ni

23 papers receiving 805 citations

Hit Papers

Iron Metabolism and Immune Regulation 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Ni China 15 395 203 195 104 87 25 817
Li Teng China 20 435 1.1× 248 1.2× 150 0.8× 102 1.0× 226 2.6× 85 1.4k
Catherine Baugé France 20 474 1.2× 78 0.4× 205 1.1× 78 0.8× 95 1.1× 45 1.2k
Guangjun Jiao China 20 824 2.1× 101 0.5× 391 2.0× 157 1.5× 143 1.6× 52 1.3k
Dhruva K. Mishra United States 18 387 1.0× 132 0.7× 145 0.7× 122 1.2× 246 2.8× 33 930
Adelheid Hainzl Germany 13 349 0.9× 118 0.6× 81 0.4× 115 1.1× 101 1.2× 18 1.3k
Maria Nurminskaya United States 18 310 0.8× 495 2.4× 57 0.3× 37 0.4× 56 0.6× 30 1.1k
Susanne Schatz Germany 4 266 0.7× 100 0.5× 63 0.3× 96 0.9× 68 0.8× 4 1.1k
Zijian Guo China 13 183 0.5× 216 1.1× 81 0.4× 76 0.7× 153 1.8× 35 786
Feng Miao China 18 191 0.5× 241 1.2× 95 0.5× 65 0.6× 240 2.8× 57 896

Countries citing papers authored by Shuo Ni

Since Specialization
Citations

This map shows the geographic impact of Shuo Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Ni more than expected).

Fields of papers citing papers by Shuo Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Ni. The network helps show where Shuo Ni may publish in the future.

Co-authorship network of co-authors of Shuo Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Ni. A scholar is included among the top collaborators of Shuo Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Ni. Shuo Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Shuo, Ning Zhu, Kexin Zhang, et al.. (2024). Optimization of extracellular polysaccharides (EPS) production by Stenotrophomonas rhizophila JC1 and its protective effect on alfalfa under Pb2+ stress. International Journal of Biological Macromolecules. 282(Pt 2). 136852–136852. 4 indexed citations
3.
Ge, Yunhao, et al.. (2023). USC-DCT: A Collection of Diverse Classification Tasks. Data. 8(10). 153–153.
4.
Zhong, Zeyuan, Chong‐Jing Zhang, Shuo Ni, et al.. (2023). NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors. Redox Biology. 63. 102711–102711. 60 indexed citations
5.
Wu, Zhongwen, Yin Yuan, Shuo Ni, et al.. (2023). An Evaluation Method of Human Gut Microbial Homeostasis by Testing Specific Fecal Microbiota. Engineering. 29. 110–119. 7 indexed citations
6.
Ge, Yunhao, Yuecheng Li, Shuo Ni, et al.. (2023). CLR: Channel-wise Lightweight Reprogramming for Continual Learning. 18752–18762. 6 indexed citations
7.
Yuan, Yin, Shuo Ni, Aoxiang Zhuge, Lanjuan Li, & Bo Li. (2022). Adipose-Derived Mesenchymal Stem Cells Reprogram M1 Macrophage Metabolism via PHD2/HIF-1α Pathway in Colitis Mice. Frontiers in Immunology. 13. 859806–859806. 32 indexed citations
8.
Yin, Yuan, Jing Yang, Aoxiang Zhuge, Lanjuan Li, & Shuo Ni. (2022). Gut microbiota modulates osteoclast glutathione synthesis and mitochondrial biogenesis in mice subjected to ovariectomy. Cell Proliferation. 55(3). e13194–e13194. 67 indexed citations
9.
Ni, Shuo, Yin Yuan, Yanbin Kuang, & Xiaolin Li. (2022). Iron Metabolism and Immune Regulation. Frontiers in Immunology. 13. 816282–816282. 149 indexed citations breakdown →
10.
Yin, Yuan, Shuo Ni, Aoxiang Zhuge, Bo Li, & Lanjuan Li. (2021). Iron Regulates the Warburg Effect and Ferroptosis in Colorectal Cancer. Frontiers in Oncology. 11. 614778–614778. 30 indexed citations
11.
Zhang, Fangxue, Xiaowei Huang, Zhi Qian, et al.. (2021). Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways. Frontiers in Pharmacology. 11. 596230–596230. 8 indexed citations
12.
Ghorbani, Farnaz, Dejian Li, Zeyuan Zhong, et al.. (2020). Bioprinting a cell‐laden matrix for bone regeneration: A focused review. Journal of Applied Polymer Science. 138(8). 18 indexed citations
13.
Yin, Yuan, Bo Li, Yanbin Kuang, et al.. (2020). The fiber metabolite butyrate reduces gp130 by targeting TRAF5 in colorectal cancer cells. Cancer Cell International. 20(1). 212–212. 6 indexed citations
14.
Zhong, Zeyuan, Zhi Qian, Xu Zhang, et al.. (2020). Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis. Frontiers in Pharmacology. 10. 1530–1530. 34 indexed citations
15.
Ni, Shuo, Yanbin Kuang, Yuan Yin, & Baoqing Yu. (2020). Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through reactive oxygen species in osteosarcoma. Cancer Cell International. 20(1). 399–399. 38 indexed citations
16.
Zhang, Fangxue, Fancheng Chen, Shuo Ni, et al.. (2020). Finite element analysis of dual small plate fixation and single plate fixation for treatment of midshaft clavicle fractures. Journal of Orthopaedic Surgery and Research. 15(1). 148–148. 25 indexed citations
17.
Qian, Zhi, Zeyuan Zhong, Shuo Ni, et al.. (2020). Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL‐induced osteoclastogenesis. Journal of Cellular and Molecular Medicine. 24(17). 10112–10127. 21 indexed citations
18.
Ni, Shuo, Zhi Qian, Yuan Yin, et al.. (2020). Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling. Cell Proliferation. 53(10). e12882–e12882. 57 indexed citations
19.
Cao, Yang, et al.. (2017). Interferonregulatoryfactor-8(IRF-8) regulates the expression of matrix metalloproteinase-13 (MMP-13) in chondrocytes. Cell Stress and Chaperones. 23(3). 393–398. 12 indexed citations
20.
Li, Peng, Weiguo Zhang, Hongquan Yu, et al.. (2016). Applying Electrospun Gelatin/Poly(lactic acid-co-glycolic acid) Bilayered Nanofibers to Fabrication of Meniscal Tissue Engineering Scaffold. Journal of Nanoscience and Nanotechnology. 16(5). 4718–4726. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026